These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. A new enteral diet, MHN-02, which contains abundant antioxidants and whey peptide, protects against carbon tetrachloride-induced hepatitis. Takayanagi T; Sasaki H; Kawashima A; Mizuochi Y; Hirate H; Sugiura T; Azami T; Asai K; Sobue K JPEN J Parenter Enteral Nutr; 2011 Jul; 35(4):516-22. PubMed ID: 21700967 [TBL] [Abstract][Full Text] [Related]
31. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions]. Ferenci P; Funovics J; Wewalka F Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563 [TBL] [Abstract][Full Text] [Related]
32. Increased hepatotoxicity of carbon tetrachloride by the hypolipidemic drug nafenopin in rats. Charpentier D; Tuchweber B Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):449-61. PubMed ID: 6289397 [TBL] [Abstract][Full Text] [Related]
33. [Parenteral and enteral nutritional support for patients with liver cirrhosis]. Masuzawa M; Okuyama T; Kato M Nihon Rinsho; 1994 Jan; 52(1):203-8. PubMed ID: 8114294 [TBL] [Abstract][Full Text] [Related]
34. Branched chain amino acids in liver disease: fact or fantasy? Silk DB Gut; 1986 Nov; 27 Suppl 1(Suppl 1):103-10. PubMed ID: 3098636 [No Abstract] [Full Text] [Related]
35. The etiology of hepatic encephalopathy - nutritional implications. Fischer JE Acta Chir Scand Suppl; 1981; 507():50-68. PubMed ID: 6797207 [No Abstract] [Full Text] [Related]
36. Nutrition support of the adult liver transplant candidate. Shronts EP; Teasley KM; Thoele SL; Cerra FB J Am Diet Assoc; 1987 Apr; 87(4):441-8, 451. PubMed ID: 3104437 [TBL] [Abstract][Full Text] [Related]
37. The influence of partial hepatectomy and carbon tetrachloride on rat stomachs. Cho CH; Sein GM; Ogle CW; Lee SD; Wang JY Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):121-4. PubMed ID: 3749606 [TBL] [Abstract][Full Text] [Related]
38. Role of enteral and parenteral nutrition in the patient with gastrointestinal and liver disease. Stratton RJ; Smith TR Best Pract Res Clin Gastroenterol; 2006; 20(3):441-66. PubMed ID: 16782523 [TBL] [Abstract][Full Text] [Related]
39. Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy. Mumtaz S; Ford AC Am J Gastroenterol; 2011 Sep; 106(9):1718; author reply 1718-9. PubMed ID: 21897411 [No Abstract] [Full Text] [Related]
40. Nutritional therapy for patients with liver disease. Sanowski RA Ariz Med; 1984 Feb; 41(2):92-4. PubMed ID: 6422911 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]